Altucell develops cell, molecular and regenerative therapy for the treatment of diabetes and other autoimmune and neurodegenerative diseases... Read more
Altucell develops cell, molecular and regenerative therapy for the treatment of diabetes and other autoimmune and neurodegenerative diseases... Read more
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Aug 22, 2023
PRcom
Press Release: Altucell, Inc. : Altucell Advances First-Ever Regulatory-Approved Human Islet Cell Encapsulation Therapy for Type 1 Diabetes
Jan 15, 2021
Benzinga
Altucell, Inc.: AltuCell Therapeutics Announces Proof-of-Concept in Lead Programs in Type 1 Diabetes in Human Subjects; Phase 1 Pilot in Humans Has IND Approval & Trial to Begin Shortly
Nov 26, 2019
The Business Journals: South Florida
Altucell: Broward company to acquire majority interest in biotechnology firm
Nov 25, 2019
firstwordpharma
Altucell: Generex Biotechnology Signs Stock Purchase Agreement to Acquire 51% of ALTuCELL
Nov 05, 2019
BioSpace
Altucell: Generex Biotechnology Announces First-in-Human Clinical Trial of the ALTuCELL Cellular Therapy Product Altsulin® (Microencapsulated Sertoli Cells)
Sep 09, 2019
GlobeNewswire
Press Release: Altucell : Generex Biotechnology Signs Letter of Intent to Acquire 51% in ALTuCELL, Inc. and their Cellular Therapy Product Altsulin® with Patented Microencapsulation Technology for the Treatment of Type I Diabetes Mellitis
Sep 09, 2019
Seeking Alpha
Altucell: Generex Bio to acquire majority interest in ALTuCELL; shares up 11%